Troubled US biotech Aeterna Zentaris has called in outside help to assist with a strategic review after a disastrous few months that saw the company axe its CEO, David Dodd.
The charity Cancer Research UK has joined with Biotecnol to begin early-stage clinical trials of a new kind of cancer immunotherapy in solid tumours, including lung cancers.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
